Stay updated on Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference2%

- Check29 days agoChange DetectedKey additions provide updated results posting, date, and clarified trial design (three cohorts, eligibility, primary objective). The deletions remove an older version of the same trial description, replacing it with the newer, more detailed text.SummaryDifference70%

- Check43 days agoChange DetectedPage revision updated to v3.0.2 and the Back to Top control was removed; the v3.0.1 tag is deleted.SummaryDifference0.1%

- Check50 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe web page has added specific medical terms related to respiratory diseases and a new facility name and location, while removing several previous location details and references to genetic resources.SummaryDifference3%

- Check72 days agoChange DetectedThe page has been updated to reflect that results have now been submitted, and the revision number has changed from v2.16.11 to v2.16.12.SummaryDifference0.1%

Stay in the know with updates to Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bemcentinib-Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.